HUMHumana

$422.30+59% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +18% year on year, but earnings down −19% year on year.

1 good, 1 to watch, 1 neutral
Revenue trend+18% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Earnings trend−19% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−0.9 points operating

Trailing-twelve-month operating margin, 1.6% now against 2.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 77% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is HUM growing?

Humana's revenue has grown 14% a year over three years, and grown 13% a year over five, with earnings per share falling 27% a year.

+14%

Revenue growth, 3-year annual rate · Healthcare Plans median +7.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+13%

Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
−27%

Earnings per share, 3-year rate · revenue +14% · earnings lagged revenue: the growth is costing something

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$83.1B
Revenue FY2022
$92.9B
Revenue FY2023
$106.4B
Revenue FY2024
$117.8B
Revenue FY2025
$129.7B

Annual income statements as filed with the SEC.